Search

Your search keyword '"Raber-Durlacher, Judith E."' showing total 262 results
Start Over Author "Raber-Durlacher, Judith E."
262 results on '"Raber-Durlacher, Judith E."'

8. The effect of conditioning regimen and prescribed medications on hyposalivation in haematopoietic cell transplantation (HCT) patients: an 18-month prospective longitudinal study

Author

Bulthuis, Marjolein S., van Gennip, Lucky L. A., Thomas, Renske Z., Bronkhorst, Ewald M., Laheij, Alexa M. G. A., Raber-Durlacher, Judith E., Rozema, Frederik R., Brennan, Michael T., von Bültzingslöwen, Inger, Blijlevens, Nicole M. A., Huysmans, Marie-Charlotte D. N. J. M., and van Leeuwen, Stephanie J. M.

Published
2023
Full Text
View/download PDF

9. Self-reported outcomes on oral health and oral health-related quality of life in long-term childhood cancer survivors—A DCCSS-LATER 2 Study

Author

Stolze, Juliette, Raber-Durlacher, Judith E., Loonen, Jacqueline J., Teepen, Jop C., Ronckers, Cécile M., Tissing, Wim J. E., de Vries, Andrica C. H., Neggers, Sebastian J. C. M. M., Dulmen-den Broeder, Eline, Heuvel-Eibrink, Marry M., van der Pal, Helena J. H., Versluys, A. Birgitta, Heiden-van der Loo, Margriet, Louwerens, Marloes, Kremer, Leontien C. M., Bresters, Dorine, and Brand, Henk S.

Published
2023
Full Text
View/download PDF

10. Subjective Oral Dryness following Hematopoietic Cell Transplantation: A Report from the Orastem Study

Author

Bulthuis, Marjolein S., van Leeuwen, Stephanie J.M., Thomas, Renske Z., van Gennip, Lucky L.A., Whiteside, Heidi M., Isom, Scott, Kline, David M., Laheij, Alexa M.G.A., Raber-Durlacher, Judith E., Hasséus, Bengt, Johansson, Jan-Erik, Hovan, Allan J., Brennan, Michael T., von Bültzingslöwen, Inger, Huysmans, Marie-Charlotte D.N.J.M., and Blijlevens, Nicole M.A.

Published
2024
Full Text
View/download PDF

16. Pre-Chemotherapy Dental Screening

Author

Zecha, Judith A.E.M., Laheij, Alexa M.G.A., Raber-Durlacher, Judith E., Westermann, Anneke M., de Lange, Jan, Smeele, Ludwig E., Academic Centre for Dentistry Amsterdam, Oral Medicine, Oral Kinesiology, Maxillofacial Surgery (AMC + VUmc), Graduate School, Oral and Maxillofacial Surgery, CCA - Cancer Treatment and Quality of Life, Other Research, Oncology, CCA -Cancer Center Amsterdam, AMS - Rehabilitation & Development, and AMS - Tissue Function & Regeneration

Subjects
dental focal infection, febrile neutropenia, SDG 3 - Good Health and Well-being, oral foci, dental screening, panoramic radiograph, cancer chemotherapy, General Dentistry
Abstract

Background: The oral cavity is a potential source of infectious complications in patients treated with myelosuppressive chemotherapy (CT). Pre-chemotherapy oral examination to identify foci of infection is recommended, but it is unclear whether this should include panoramic radiography. The present study aimed to evaluate the additional diagnostic merit of panoramic radiography as part of pre-CT oral screening. Methods: Patients with solid tumors scheduled to receive a myelosuppressive CT were eligible. The foci definition followed the guidelines of the Dutch Association of Maxillofacial Surgery. Oral foci assessed by clinical evaluation and panoramic radiography were compared. Results: In 33 out of 93 patients (35.5%), one or more foci were identified by clinical examination, whereas in 49.5% of patients, panoramic radiography showed pathology. In 19 patients, an oral focus was missed by clinical examination only, whereas in 11 patients, panoramic radiography indicated periodontal bone loss, but advanced periodontitis was not substantiated by clinical examination. Conclusions: Panoramic radiographs complement clinical examinations and have additional diagnostic value. Nevertheless, the additional merit seems small, and the clinical relevance may vary depending on the anticipated risk of developing oral complications and the need for detailed diagnosis and rigorous elimination of oral foci prior to the start of cancer therapy.

Published
2023

18. Photobiomodulation therapy in management of cancer therapy-induced side effects

Author

Robijns, Jolien, Nair, Raj G., Lodewijckx, Joy, Arany, Praveen, Barasch, Andrei, Bjordal, Jan Magnus, Bossi, Paolo, Chilles, Anne, Corby, Patricia M., Epstein, Joel B., Elad, Sharon, Fekrazad, Reza, Fregnani, Eduardo Rodrigues, Genot, Marie-Thérèse, Ibarra, Ana M. C., Hamblin, Michael R., Heiskanen, Vladimir, Hu, Ken, Klastersky, Jean, Lalla, Rajesh, Latifian, Sofia, Maiya, Arun, Mebis, Jeroen, Migliorati, Cesar A., Milstein, Dan M. J., Murphy, Barbara, Raber-Durlacher, Judith E., Roseboom, Hendrik J., Sonis, Stephen, Treister, Nathaniel, Zadik, Yehuda, Bensadoun, René-Jean, ROBIJNS, Jolien, LODEWIJCKX, Joy, Arany, Praveen, Barasch, Andrei, Jan, Bjordal, Bossi, Paolo, Chilles, Anne, Corby, Patricia, Epstein, Joel, Elad, Sharon, Fekrazad, Reza, Fregnani, Eduardo, Genot, Marie-Thérèse, Ibarra, Ana, Hamblin, Michael, Heiskanen, Vladimir, Hu, Ken, Klastersky, Jean, Lalla, Raj, Latifian, Sofia, Maiya, Arun, MEBIS, Jeroen, Migliorati, Cesar, Milstein, Dan, Murhpy, Barbara, Raber-Durlacher, Judith, Roseboom, Hendrik, Sonis, Stephen, Treister, Nathaniel, Zadik, Yehuda, and Bensadoun, René-Jean

Subjects
cancer supportive care, cancer-treatment side effects, dermatitis, guidelines, mucositis, photobiomodulation (PBM), recommendations, Cancer Research, Oncology, SDG 3 - Good Health and Well-being
Abstract

DisclaimerThis article is based on recommendations from the 12th WALT Congress, Nice, October 3-6, 2018, and a follow-up review of the existing data and the clinical observations of an international multidisciplinary panel of clinicians and researchers with expertise in the area of supportive care in cancer and/or PBM clinical application and dosimetry. This article is informational in nature. As with all clinical materials, this paper should be used with a clear understanding that continued research and practice could result in new insights and recommendations. The review reflects the collective opinion and, as such, does not necessarily represent the opinion of any individual author. In no event shall the authors be liable for any decision made or action taken in reliance on the proposed protocols.ObjectiveThis position paper reviews the potential prophylactic and therapeutic effects of photobiomodulation (PBM) on side effects of cancer therapy, including chemotherapy (CT), radiation therapy (RT), and hematopoietic stem cell transplantation (HSCT).BackgroundThere is a considerable body of evidence supporting the efficacy of PBM for preventing oral mucositis (OM) in patients undergoing RT for head and neck cancer (HNC), CT, or HSCT. This could enhance patients’ quality of life, adherence to the prescribed cancer therapy, and treatment outcomes while reducing the cost of cancer care.MethodsA literature review on PBM effectiveness and dosimetry considerations for managing certain complications of cancer therapy were conducted. A systematic review was conducted when numerous randomized controlled trials were available. Results were presented and discussed at an international consensus meeting at the World Association of photobiomoduLation Therapy (WALT) meeting in 2018 that included world expert oncologists, radiation oncologists, oral oncologists, and oral medicine professionals, physicists, engineers, and oncology researchers. The potential mechanism of action of PBM and evidence of PBM efficacy through reported outcomes for individual indications were assessed.ResultsThere is a large body of evidence demonstrating the efficacy of PBM for preventing OM in certain cancer patient populations, as recently outlined by the Multinational Association for Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Building on these, the WALT group outlines evidence and prescribed PBM treatment parameters for prophylactic and therapeutic use in supportive care for radiodermatitis, dysphagia, xerostomia, dysgeusia, trismus, mucosal and bone necrosis, lymphedema, hand-foot syndrome, alopecia, oral and dermatologic chronic graft-versus-host disease, voice/speech alterations, peripheral neuropathy, and late fibrosis amongst cancer survivors.ConclusionsThere is robust evidence for using PBM to prevent and treat a broad range of complications in cancer care. Specific clinical practice guidelines or evidence-based expert consensus recommendations are provided. These recommendations are aimed at improving the clinical utilization of PBM therapy in supportive cancer care and promoting research in this field. It is anticipated these guidelines will be revised periodically.

Published
2022

19. Oral health in patients scheduled for hematopoietic stem cell transplantation in the Orastem study

Author

Skallsjö, Kristina, primary, von Bültzingslöwen, Inger, additional, Hasséus, Bengt, additional, Johansson, Jan-Erik, additional, Öhman, Jenny, additional, Raber-Durlacher, Judith E., additional, Huysmans, Marie-Charlotte D. N. J. M., additional, Laheij, Alexa M. G. A., additional, van Leeuwen, Stephanie J. M., additional, Hovan, Allan J., additional, Garming Legert, Karin, additional, Nguyen, Hieu M., additional, Turk, Philip J., additional, Rozema, Frederik R., additional, Blijlevens, Nicole M. A., additional, and Brennan, Michael T., additional

Published
2023
Full Text
View/download PDF

22. Microbial changes in relation to oral mucositis in autologous hematopoietic stem cell transplantation recipients

Author

Laheij, Alexa M. G. A., Raber-Durlacher, Judith E., Koppelmans, Renée G. A., Huysmans, Marie-Charlotte D. N. J. M., Potting, Carin, van Leeuwen, Stephanie J. M., Hazenberg, Mette D., Brennan, Michael T., von Bültzingslöwen, Inger, Johansson, Jan-Erik, de Soet, Johannes J., Haverman, Thijs M., Buijs, Mark J., Brandt, Bernd W., Rozema, Frederik R., Blijlevens, Nicole M. A., and Zaura, Egija

Published
2019
Full Text
View/download PDF

24. Patient-reported outcomes for immediate identification of dental care needs

Author

Güneri Pelin, Epstein Joel B., Raber-Durlacher Judith E., Çankaya Hülya, Boyacıoğlu Hayal, and Barasch Andrei

Subjects
dental care, health care delivery, oral health, patient outcomes assessment, special care, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Aim: Dental treatment is necessary in oncology patients since pre-existing oro-dental disease may influence cancer treatment and prognosis. This study investigated the applicability of two indices in reflecting the actual oral health status of 100 non-cancer patients who were admitted for dental complaints/routine controls.

Published
2015
Full Text
View/download PDF

26. Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols

Author

Zecha, Judith A. E. M., Raber-Durlacher, Judith E., Nair, Raj G., Epstein, Joel B., Elad, Sharon, Hamblin, Michael R., Barasch, Andrei, Migliorati, Cesar A., Milstein, Dan M. J., Genot, Marie-Thérèse, Lansaat, Liset, van der Brink, Ron, Arnabat-Dominguez, Josep, van der Molen, Lisette, Jacobi, Irene, van Diessen, Judi, de Lange, Jan, Smeele, Ludi E., Schubert, Mark M., and Bensadoun, René-Jean

Published
2016
Full Text
View/download PDF

27. Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations

Author

Zecha, Judith A. E. M., Raber-Durlacher, Judith E., Nair, Raj G., Epstein, Joel B., Sonis, Stephen T., Elad, Sharon, Hamblin, Michael R., Barasch, Andrei, Migliorati, Cesar A., Milstein, Dan M. J., Genot, Marie-Thérèse, Lansaat, Liset, van der Brink, Ron, Arnabat-Dominguez, Josep, van der Molen, Lisette, Jacobi, Irene, van Diessen, Judi, de Lange, Jan, Smeele, Ludi E., Schubert, Mark M., and Bensadoun, René-Jean

Published
2016
Full Text
View/download PDF

29. Prevalence and Risk Factors for Hyposalivation and Xerostomia in Childhood Cancer Survivors Following Different Treatment Modalities—A Dutch Childhood Cancer Survivor Study Late Effects 2 Clinical Study (DCCSS LATER 2)

Author

Stolze, Juliette, primary, Teepen, Jop C., additional, Raber-Durlacher, Judith E., additional, Loonen, Jacqueline J., additional, Kok, Judith L., additional, Tissing, Wim J. E., additional, de Vries, Andrica C. H., additional, Neggers, Sebastian J. C. M. M., additional, van Dulmen-den Broeder, Eline, additional, van den Heuvel-Eibrink, Marry M., additional, van der Pal, Helena J. H., additional, Versluys, A. Birgitta, additional, van der Heiden-van der Loo, Margriet, additional, Louwerens, Marloes, additional, Kremer, Leontien C. M., additional, Brand, Henk S., additional, and Bresters, Dorine, additional

Published
2022
Full Text
View/download PDF

31. Prevalence and Risk Factors for Hyposalivation and Xerostomia in Childhood Cancer Survivors Following Different Treatment Modalities-A Dutch Childhood Cancer Survivor Study Late Effects 2 Clinical Study (DCCSS LATER 2)

Author

Stolze, Juliette, Teepen, J.C., Raber-Durlacher, Judith E., Loonen, J.J., Kok, Judith L., Tissing, W.J.E., Brand, Henk S., Bresters, Dorine, Stolze, Juliette, Teepen, J.C., Raber-Durlacher, Judith E., Loonen, J.J., Kok, Judith L., Tissing, W.J.E., Brand, Henk S., and Bresters, Dorine

Abstract

Contains fulltext : 253198.pdf (Publisher’s version ) (Open Access)

Published
2022

32. Caries Progression after Haematopoietic Stem Cell Transplantation and the Role of Hyposalivation

Author

Bulthuis, M.S., Gennip, L.L.A. van, Thomas, R.Z., Bronkhorst, E.M., Laheij, Alexa M.G.A., Raber-Durlacher, Judith E., Blijlevens, N.M.A., Leeuwen, S.J.M. van, Huysmans, M.C.D.N.J.M., Bulthuis, M.S., Gennip, L.L.A. van, Thomas, R.Z., Bronkhorst, E.M., Laheij, Alexa M.G.A., Raber-Durlacher, Judith E., Blijlevens, N.M.A., Leeuwen, S.J.M. van, and Huysmans, M.C.D.N.J.M.

Abstract

Contains fulltext : 285905.pdf (Publisher’s version ) (Open Access)

Published
2022

34. Basic oral care for hematology–oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT)

Author

Elad, Sharon, Raber-Durlacher, Judith E., Brennan, Michael T., Saunders, Deborah P., Mank, Arno P., Zadik, Yehuda, Quinn, Barry, Epstein, Joel B., Blijlevens, Nicole M. A., Waltimo, Tuomas, Passweg, Jakob R., Correa, M. Elvira P., Dahllöf, Göran, Garming-Legert, Karin U. E., Logan, Richard M., Potting, Carin M. J., Shapira, Michael Y., Soga, Yoshihiko, Stringer, Jacqui, Stokman, Monique A., Vokurka, Samuel, Wallhult, Elisabeth, Yarom, Noam, and Jensen, Siri Beier

Published
2015
Full Text
View/download PDF

35. Long-Term Analysis of Resilience of the Oral Microbiome in Allogeneic Stem Cell Transplant Recipients

Author

Laheij, Alexa M. G. A., primary, Rozema, Frederik R., additional, Brennan, Michael T., additional, von Bültzingslöwen, Inger, additional, van Leeuwen, Stephanie J. M., additional, Potting, Carin, additional, Huysmans, Marie-Charlotte D. N. J. M., additional, Hazenberg, Mette D., additional, Brandt, Bernd W., additional, Zaura, Egija, additional, Buijs, Mark J., additional, de Soet, Johannes J., additional, Blijlevens, Nicole N. M., additional, and Raber-Durlacher, Judith E., additional

Published
2022
Full Text
View/download PDF

36. Oral Care for Hematopoietic Stem Cell Transplantation Patients: A Narrative Review.

Author

Samim, Firoozeh, ten Böhmer, Kim L., Koppelmans, Renée G. A., Raber-Durlacher, Judith E., and Epstein, Joel B.

Subjects
HEMATOPOIETIC stem cell transplantation, POPULATION health management, INFECTION prevention, CAVITY prevention, DENTAL care
Abstract

Purpose: Patients undergoing hematopoietic stem cell transplantation (HSCT) are at high risk of oral complications with the potential of causing significant morbidity and mortality. Dental professionals should play a fundamental role in the prevention and treatment of oral sequelae of HSCT. However, the dental community is not well informed and experienced in providing oral care of the oral complications for HSCT patients. This narrative review attempts to fill the knowledge gap through reviewing the oral complications and current recommendations for oral and dental care for the patient before, during and after HSCT.Results: Oral care in the HSCT process was divided into five stages with the goal being to provide practical guidance for dental care providers to assist in managing these patients. It is well known that the maintenance of good oral health is important in cancer patients, including patients with hematologic malignancies. In addition to negatively impacting quality of life, oral pain and/or infections can cause delays, modification and discontinuation of life-saving cancer treatment. Oral complications can lead to new or extended hospitalization. By providing a preventive and treatment algorithm based on currently available literature reports and expert opinion, we can hope to achieve better patient outcomes.Conclusion: We present oral and dental management recommendations with a focus on oral health maintenance, infection prevention, pain control and oral complication management to support oral and general health of this medically complex patient population prior to, during and following HSCT. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

37. Caries Progression after Haematopoietic Stem Cell Transplantation and the Role of Hyposalivation

Author

Bulthuis, Marjolein S., primary, van Gennip, Lucky L.A., additional, Thomas, Renske Z., additional, Bronkhorst, Ewald M., additional, Laheij, Alexa M.G.A., additional, Raber-Durlacher, Judith E., additional, Rozema, Frederik R., additional, Brennan, Michael T., additional, von Bültzingslöwen, Inger, additional, Blijlevens, Nicole M.A., additional, van Leeuwen, Stephanie J.M., additional, and Huysmans, Marie-Charlotte D.N.J.M., additional

Published
2022
Full Text
View/download PDF

40. Long-Term Effects of Childhood Cancer Treatment on Dentition and Oral Health: A Dentist Survey Study from the DCCSS LATER 2 Study

Author

Stolze, Juliette, primary, Vlaanderen, Kim C. E., additional, Holtbach, Frederique C. E. D., additional, Teepen, Jop C., additional, Kremer, Leontien C. M., additional, Loonen, Jacqueline J., additional, van Dulmen-den Broeder, Eline, additional, Heuvel-Eibrink, Marry M. van den, additional, Pal, Helena J. H. van der, additional, Versluys, Birgitta, additional, van der Heiden-van der Loo, Margriet, additional, Louwerens, Marloes, additional, Raber-Durlacher, Judith E., additional, Bresters, Dorine, additional, and Brand, Henk S., additional

Published
2021
Full Text
View/download PDF

42. Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients

Author

Raber-Durlacher, Judith E., von Bültzingslöwen, Inger, Logan, Richard M., Bowen, Joanne, Al-Azri, Abdul Rahman, Everaus, Hele, Gerber, Erich, Gomez, Jesùs Garcia, Pettersson, Bo G., Soga, Yoshihiko, Spijkervet, Fred K. L., Tissing, Wim J. E., Epstein, Joel B., Elad, Sharon, Lalla, Rajesh V., and For the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO)

Published
2013
Full Text
View/download PDF

44. Long-Term Effects of Childhood Cancer Treatment on Dentition and Oral Health: A Dentist Survey Study from the DCCSS LATER 2 Study

Author

Zorg en O&O, Child Health, SCT patientenzorg, Stolze, Juliette, Vlaanderen, Kim C E, Holtbach, Frederique C E D, Teepen, Jop C, Kremer, Leontien C M, Loonen, Jacqueline J, van Dulmen-den Broeder, Eline, Heuvel-Eibrink, Marry M van den, Pal, Helena J H van der, Versluys, Birgitta, van der Heiden-van der Loo, Margriet, Louwerens, Marloes, Raber-Durlacher, Judith E, Bresters, Dorine, Brand, Henk S, Zorg en O&O, Child Health, SCT patientenzorg, Stolze, Juliette, Vlaanderen, Kim C E, Holtbach, Frederique C E D, Teepen, Jop C, Kremer, Leontien C M, Loonen, Jacqueline J, van Dulmen-den Broeder, Eline, Heuvel-Eibrink, Marry M van den, Pal, Helena J H van der, Versluys, Birgitta, van der Heiden-van der Loo, Margriet, Louwerens, Marloes, Raber-Durlacher, Judith E, Bresters, Dorine, and Brand, Henk S

Published
2021

46. Swallowing dysfunction in cancer patients

Author

Raber-Durlacher, Judith E., Brennan, Mike T., Verdonck-de Leeuw, Irma M., Gibson, Rachel J., Eilers, June G., Waltimo, Tuomas, Bots, Casper P., Michelet, Marisol, Sollecito, Thomas P., Rouleau, Tanya S., Sewnaik, Aniel, Bensadoun, Rene-Jean, Fliedner, Monica C., Silverman, Jr, Sol, Spijkervet, Fred K. L., and Dysphagia Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO)

Published
2012
Full Text
View/download PDF

48. Oral chronic graft-versus-host disease: What the general dental practitioner needs to know

Author

Haverman, Thijs M., Raber-Durlacher, Judith E., Raghoebar, Iva I., Rademacher, Willem M. H., Rozema, Frederik R., Hazenberg, Mette D., Epstein, Joel B., Treister, Nathaniel S., Graduate School, Other Research, Oral and Maxillofacial Surgery, and Clinical Haematology

Subjects
Oral graft-versus-host-disease, trismus, stomatognathic diseases, stomatognathic system, dental treatment, immune system diseases, oral care, hematopoietic stem cell transplantation, oral candidiasis, xerostomia, hyposalivation, caries
Abstract

Background: Long-term survivors of allogeneic hematopoietic cell transplantation will increasingly seek care from dental providers. Methods: The authors highlight the importance of minimizing oral symptoms and complications associated with oral chronic graft-versus-host-disease (cGVHD). Results: Chronic GVHD is the result of an immune response of donor-derived cells against recipient tissues. Oral cGVHD can affect the mucosa and damage salivary glands and cause sclerotic changes. Symptoms include sensitivity and pain, dry mouth, taste changes, and limited mouth opening. Risk of developing caries and oral cancer is increased. Food intake, oral hygiene, and dental interventions can represent challenges. Oral cGVHD manifestations and dental interventions should be managed in close consultation with the medical team, as systemic treatment for cGVHD can have implications for dental management. Conclusions: General dental practitioners can contribute substantially to alleviating oral cGVHD involvement and preventing additional oral health deterioration. Practical Implications: Frequent examinations, patient education, oral hygiene reinforcement, dry mouth management, caries prevention, and management of dental needs are indicated. In addition, oral physical therapy might be needed. Invasive dental interventions should be coordinated with the transplantation team. Screening for oral malignancies is important even years after resolution of GVHD symptoms. Management of the oral manifestations of cGVHD might require referral to an oral medicine professional.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results